Association between coronary artery calcium score and in-stent restenosis after drug-eluting stent implantation.
Zheng X, Xu K, Yang X, Yang W, Zhang W, Jiang Y, Zhang Y, Qiu X, Shi H, Jiang L, Shen L, He B.
Coron Artery Dis. 2022 Jun 1;33(4):284-294. doi: 10.1097/MCA.0000000000001124. Epub 2022 Jan 25.
PMID:35085159
What is the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent implantation?
Basaraba JE, Barry AR.
Am J Health Syst Pharm. 2016 May 1;73(9):e229-37. doi: 10.2146/ajhp150655.
PMID:27099329
Evaluation and management of drug-eluting stent in-stent restenosis.
Parfrey S, Siu V, Graham JJ, Vijayaraghavan R, Li C, Pang J, Kalra S, Džavík V, Wijeysundera HC, Bagai A; from the University of Toronto CTO Collaborative.
Drug-Coated Balloon in Primary Percutaneous Coronary Intervention.
Zhao H, Miao R, Lin F, Zhao G.
J Interv Cardiol. 2023 Jun 26;2023:5210808. doi: 10.1155/2023/5210808. eCollection 2023.
PMID:37404481
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion.